Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Carlos R Montes-de-Oca-SaucedoDepartamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Mexico.ORCID 0000-0002-2355-2217
Jonathan E Perales-MartínezDepartamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.
Juan C Arellano-BarrientosDepartamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Mexico.
Luis E Rodríguez-TovarDepartamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.
Alicia M Nevárez-GarzaDepartamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.
Aimé J Garza-ArredondoDepartamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.
Odila Saucedo-CárdenasDepartamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Mexico.ORCID 0000-0003-3922-2615
Gustavo Hernández-VidalCuerpo Académico de Patobiología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.
Adolfo Soto-DomínguezDepartamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Mexico.ORCID 0000-0002-4144-5474
Uziel Castillo-VelázquezDepartamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico.ORCID 0000-0002-0342-1703
Funding
Programa de Apoyo a la Ciencia, Tecnología e Innovación ProACTI 2024 (UANL). Clave No. 29-MCS-2024.
6 · The paper itself
Abstract
Cannabidiol (CBD), a phytocannabinoid derived from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Targeting Human Cancer Cells with Cannabidiol (CBD): Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines. · full record | OpenQuestion